U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07495722) titled 'Safely Quenching Complement in Stroke Survivors' on March 18.
Brief Summary: This study will include adults (ages 18-80) who have had a stroke caused by a large blood clot blocking blood flow in the brain. All patients in the study must have already had a treatment called a thrombectomy, where doctors remove the clot to help blood flow return to the brain.
The goal of this study is to test the safety of a drug called EMPAVELI (pegcetacoplan). This drug is meant to lower swelling and inflammation that can happen after blood flow returns. The hope is that it may help protect the brain from more damage and improve recovery.
People i...